Photoreactive Stapled BH3 Peptides to Dissect the BCL-2 Family Interactome

Department of Pediatric Oncology, Dana-Farber Cancer Institute and Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA.
Chemistry & biology (Impact Factor: 6.65). 12/2010; 17(12):1325-33. DOI: 10.1016/j.chembiol.2010.09.015
Source: PubMed


Defining protein interactions forms the basis for discovery of biological pathways, disease mechanisms, and opportunities for therapeutic intervention. To harness the robust binding affinity and selectivity of structured peptides for interactome discovery, we engineered photoreactive stapled BH3 peptide helices that covalently capture their physiologic BCL-2 family targets. The crosslinking α helices covalently trap both static and dynamic protein interactors, and enable rapid identification of interaction sites, providing a critical link between interactome discovery and targeted drug design.

Download full-text


Available from: Evripidis Gavathiotis
  • Source
    • "The eluates were electrophoresed using 4%–12% gradient Bis-Tris gels (Invitrogen) and then stained for protein content by Coomassie blue. The crosslinked bands were excised and prepared for mass spectrometry analysis as previously described (Braun et al., 2010). Samples were subjected to liquid chromatography-tandem mass spectrometry (LC-MS/MS) in an LTQ Orbitrap XL hybrid mass spectrometer (Thermo Fisher Scientific). "
    [Show abstract] [Hide abstract]
    ABSTRACT: PUMA is a proapoptotic BCL-2 family member that drives the apoptotic response to a diversity of cellular insults. Deciphering the spectrum of PUMA interactions that confer its context-dependent proapoptotic properties remains a high priority goal. Here, we report the synthesis of PUMA SAHBs, structurally stabilized PUMA BH3 helices that, in addition to broadly targeting antiapoptotic proteins, directly bind to proapoptotic BAX. NMR, photocrosslinking, and biochemical analyses revealed that PUMA SAHBs engage an α1/α6 trigger site on BAX to initiate its functional activation. We further demonstrated that a cell-permeable PUMA SAHB analog induces apoptosis in neuroblastoma cells and, like expressed PUMA protein, engages BCL-2, MCL-1, and BAX. Thus, we find that PUMA BH3 is a dual antiapoptotic inhibitor and proapoptotic direct activator, and its mimetics may serve as effective pharmacologic triggers of apoptosis in resistant human cancers.
    Full-text · Article · Jul 2013 · Chemistry & biology
  • Source
    • "Stabilized α-helix, SAH, is a stapled peptide to p53 that has been shown to prevent p53-MDM4 binding, enabling activation of p53 response and tumor growth suppression both in vitro and in vivo models [104]. Recently, engineered photoreactive stapled BH3 peptide helices covalently trap both static and dynamic protein interactors, and enable rapid identification of interaction sites, providing a new scope for targeted drug design for the BCL-2 family targets [105]. Visualizing potential sites on Gabs for similar stapled peptides can provide fascinating insights into protein-binding disruption. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The Grb-2 associated binder (Gab) family of scaffolding/adaptor/docking proteins is a group of three molecules with significant roles in cytokine receptor signaling. Gabs possess structural motifs for phosphorylation-dependent receptor recruitment, Grb2 binding, and activation of downstream signaling pathways through p85 and SHP-2. In addition, Gabs participate in hematopoiesis and regulation of immune response which can be aberrantly activated in cancer and inflammation. The multifunctionality of Gab adapters might suggest that they would be too difficult to consider as candidates for "targeted" therapy. However, the one drug/one target approach is giving way to the concept of one drug/multiple target approach since few cancers are addicted to a single signaling molecule for survival and combination drug therapies can be problematic. In this paper, we cover recent findings on Gab multi-functionality, binding partners, and their role in hematological malignancy and examine the concept of Gab-targeted therapy.
    Full-text · Article · Jan 2012 · Advances in Hematology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Protein-protein interactions play a major role in almost all biological pathways and thus, these interactions have a profound impact on the pathogenesis of diseases. The ability to modulate protein-protein interactions with small molecules is an important and rapidly growing area in the field of medicinal chemistry. One of the most common secondary protein structures that are involved in protein-protein interactions are α-helices. Thus, a common approach towards developing inhibitors of protein-protein interactions is to design non-peptidic small molecules that mimic the spatial orientations of the side chains of an α-helix. In this review, we will discuss a variety of small molecules including terephenyls, terephthalamides, benzamides, enaminones, benzoylureas, pyridines, imidazoles, thiazoles, pyridazines, piperazines, oxopiperazines and diphenylindanes that have been published from 2005-2010 as small molecule α- helical mimetics.
    No preview · Article · Jun 2011 · Current Medicinal Chemistry
Show more